Ranjit Manchanda

Ranjit Manchanda is a Professor at the Wolfson Institute of Population Health (WIPH), Queen Mary University of London, and leads the Women's Precision Prevention Team. He co-leads the Cancer Screening, Prevention and Epidemiology Unit at the Centre for Cancer Screening, Prevention & Early Diagnosis within WIPH. He is a Consultant Gynaecological Oncologist at Barts Health NHS Trust.

He holds an Honorary Professorship in the Department of Health Services Research, London School of Hygiene & Tropical Medicine. His main research interests are focused on targeted precision prevention. He leads a number of studies across population-based genetic testing, mainstreaming genetic testing, and precision medicine approaches for risk prediction, stratification, targeted screening and targeted cancer prevention, along with health economic issues related to these areas of research. He is an NHS Innovation Accelerator Alumnus, the Topic Advisor (Clinical Lead) for NICE guideline NG241, co-leads the SPED working group of the Lancet Commission on Ovarian Cancer, and is a member of the ESGO Council.